Entresto 6 mg/6 mg
Entresto 6 mg/6 mg is a medicine authorised by Swissmedic under authorisation number 69255. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 August 2024 and the authorisation is limited until 20 August 2029. ATC code C09DX04 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 69255 |
|---|---|
| Name | Entresto 6 mg/6 mg |
| Full name | Entresto 6 mg/6 mg, filmüberzogenes Granulat |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DX04 |
| First authorisation | 21 August 2024 |
| Authorisation validity | 20 August 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Entresto 6 mg/6 mg, filmüberzogenes Granulat | B | 21 August 2024 |
| 2 | Entresto 15 mg/16 mg, filmüberzogenes Granulat | B | 21 August 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Kapsel(n) | C09DX04 | 02.07.2. | B |
| 2 | 60 | Kapsel(n) | C09DX04 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Entresto 6 mg/6 mg authorised in Switzerland?
Yes. Entresto 6 mg/6 mg is authorised by Swissmedic under authorisation number 69255, data as of 01 September 2026. The authorisation is limited until 20 August 2029.
Which dispensing category does Entresto 6 mg/6 mg have?
Entresto 6 mg/6 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Entresto 6 mg/6 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.